According to Borui Pharmaceutical's announcement, Yuan Jiandong, the company's controlling shareholder and actual controller, Zhong Weifang, and his co-operator, Bo Ruixin, issued a letter of commitment. From November 12, 2026 to May 11, 2027, they will not reduce their holdings of the company's shares in any way, and that additional shares such as transfers, stock transfers, and allotments during the commitment period will also abide by this promise. As of the disclosure date of the announcement, the above undertakers held a total of 163 million shares of the company, accounting for 37.38% of the company's total share capital.

According to Borui Pharmaceutical's announcement, Yuan Jiandong, the company's controlling shareholder and actual controller, Zhong Weifang, and his co-operator, Bo Ruixin, issued a letter of commitment. From November 12, 2026 to May 11, 2027, they will not reduce their holdings of the company's shares in any way, and that additional shares such as transfers, stock transfers, and allotments during the commitment period will also abide by this promise. As of the disclosure date of the announcement, the above undertakers held a total of 163 million shares of the company, accounting for 37.38% of the company's total share capital.